Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update

被引:6
作者
Vaz-Salvador, Pedro [1 ]
Adao, Rui [1 ]
Vasconcelos, Ines [1 ]
Leite-Moreira, Adelino F. [1 ]
Bras-Silva, Carmen [1 ,2 ]
机构
[1] Univ Porto, Fac Med, Cardiovasc Res & Dev Ctr UnIC, Dept Surg & Physiol, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal
[2] Univ Porto, Fac Nutr & Food Sci, Rua Campo Alegre, P-823415018 Porto, Portugal
关键词
Heart failure; Preserved ejection fraction; Pharmacotherapy; Clinical trials; QUALITY-OF-LIFE; CONVERTING ENZYME-INHIBITION; SOLUBLE GUANYLATE-CYCLASE; CORONARY-ARTERY-DISEASE; EXERCISE CAPACITY; DOUBLE-BLIND; DIASTOLIC DYSFUNCTION; IRON-DEFICIENCY; ECONOMIC BURDEN; CLINICAL STATUS;
D O I
10.1007/s10557-021-07306-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While guidelines for management of heart failure with reduced ejection fraction (HFrEF) are consensual and have led to improved survival, treatment options for heart failure with preserved ejection fraction (HFpEF) remain limited and aim primarily for symptom relief and improvement of quality of life. Due to the shortage of therapeutic options, several drugs have been investigated in multiple clinical trials. The majority of these trials have reported disappointing results and have suggested that HFpEF might not be as simply described by ejection fraction as previously though. In fact, HFpEF is a complex clinical syndrome with various comorbidities and overlapping distinct phenotypes that could benefit from personalized therapeutic approaches. This review summarizes the results from the most recent phase III clinical trials for HFpEF and the most promising drugs arising from phase II trials as well as the various challenges that are currently holding back the development of new pharmacotherapeutic options for these patients.
引用
收藏
页码:815 / 832
页数:18
相关论文
共 121 条
[1]   Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction [J].
Abudiab, Muaz M. ;
Redfield, Margaret M. ;
Melenovsky, Vojtech ;
Olson, Thomas P. ;
Kass, David A. ;
Johnson, Bruce D. ;
Borlaug, Barry A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (07) :776-785
[2]   Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction [J].
Alcaide-Aldeano, Alex ;
Garay, Alberto ;
Alcoberro, Lidia ;
Jimenez-Marrero, Santiago ;
Yun, Sergi ;
Tajes, Marta ;
Garcia-Romero, Elena ;
Diez-Lopez, Carles ;
Gonzalez-Costello, Jose ;
Mateus-Porta, Gemma ;
Cainzos-Achirica, Miguel ;
Enjuanes, Cristina ;
Comin-Colet, Josep ;
Moliner, Pedro .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[3]   Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications [J].
Altenberger, Johann ;
Gustafsson, Finn ;
Harjola, Veli-Pekka ;
Karason, Kristjan ;
Kindgen-Milles, Detlef ;
Kivikko, Matti ;
Malfatto, Gabriella ;
Papp, Zoltan ;
Parissis, John ;
Pollesello, Piero ;
Poelzl, Gerhard ;
Tschoepe, Carsten .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 71 (03) :129-136
[4]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[5]   Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial [J].
Armstrong, Paul W. ;
Lam, Carolyn S. P. ;
Anstrom, Kevin J. ;
Ezekowitz, Justin ;
Hernandez, Adrian F. ;
O'Connor, Christopher M. ;
Pieske, Burkert ;
Ponikowski, Piotr ;
Shah, Sanjiv J. ;
Solomon, Scott D. ;
Voors, Adriaan A. ;
She, Lilin ;
Vlajnic, Vanja ;
Carvalho, Francine ;
Bamber, Luke ;
Blaustein, Robert O. ;
Roessig, Lothar ;
Butler, Javed .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (15) :1512-1521
[6]   EFFECT OF LISINOPRIL AND METOPROLOL ON ARTERIAL DISTENSIBILITY [J].
BARENBROCK, M ;
SPIEKER, C ;
HOEKS, APG ;
ZIDEK, W ;
RAHN, KH .
HYPERTENSION, 1994, 23 (01) :I161-I163
[7]   Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis [J].
Beale, Anna L. ;
Warren, Josephine Lillian ;
Roberts, Nia ;
Meyer, Philippe ;
Townsend, Nick P. ;
Kaye, David .
OPEN HEART, 2019, 6 (01)
[8]   Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study [J].
Beattie, James M. ;
Khatib, Rani ;
Phillips, Ceri J. ;
Williams, Simon G. .
OPEN HEART, 2020, 7 (01)
[9]   Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life [J].
Bekfani, Tarek ;
Pellicori, Pierpaolo ;
Morris, Daniel ;
Ebner, Nicole ;
Valentova, Miroslava ;
Sandek, Anja ;
Doehner, Wolfram ;
Cleland, John G. ;
Lainscak, Mitja ;
Schulze, P. Christian ;
Anker, Stefan D. ;
von Haehling, Stephan .
CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (02) :203-211
[10]   Mechanisms of diastolic dysfunction in heart failure [J].
Borlaug, Barry A. ;
Kass, David A. .
TRENDS IN CARDIOVASCULAR MEDICINE, 2006, 16 (08) :273-279